Skip to main content

Find Clinical Trials

Home
Conditions
Mosquito-Borne Diseases

Clinical trial condition

Mosquito-Borne Diseases

Explore clinical trials studying Mosquito-Borne Diseases. Study availability and eligibility vary by location and protocol.

1,584 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Mosquito-Borne Diseases trial results

Completed

A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan

NCT06741683

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations: PS Clinic Fukuoka, Japan

Saitama City Hospital Saitama-shi, Saitama, Japan

Sumida Hospital Sumida-ku, Tokyo, Japan

OKURA Otolaryngology Clinic Toshima-ku, Tokyo, Japan

View Trial Details

Completed

Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

NCT05979207

Conditions: Anti-Infective Agents, Antimalarials, Infections, +14 more
Locations: South Bank Brisbane, Queensland, Australia

USC Clinical Trials, Morayfield Brisbane, Queensland, Australia

View Trial Details

Completed

Pilot Study to Detect DENGUE Virus in Sperm

NCT03612609

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
Locations: Hôpital Saint-Pierre Saint-Pierre, Reunion

View Trial Details

Completed

Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria

NCT06992297

Conditions: Falciparum Malaria, Infections, Malaria, +5 more
Locations: Assistance Publique Hopitaux de Marseille Marseille, France

View Trial Details

Completed

Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults

NCT02658253

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: CNRFP Ouagadougou, Burkina Faso

CIC 1417 Paris, France

View Trial Details

Completed

Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults

NCT02014727

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: CNRFP Ouagadougou, Burkina Faso

CIC BT 505 de vaccinologie Cochin Pasteur. Hôpital Cochin Bâtiment Lavoisier 27 rue du faubourg St Jacques. Paris, France

View Trial Details

Completed

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults

NCT05913973

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)

NCT04514107

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +12 more
Locations: Universidade Federal de Minas Gerais, Instituto de Ciencias Biologicas, Department of Biochemistry and Immunology Belo Horizonte, Minas Gerais, Brazil

View Trial Details

Completed

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria

NCT07235020

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Novartis Investigative Site Banfora, Burkina Faso

Novartis Investigative Site Azaguié, Côte d’Ivoire

Novartis Investigative Site Lambaréné, Gabon

Novartis Investigative Site Navrongo, Ghana

View Trial Details

Completed

Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)

NCT05710224

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
Locations: Hospital Tacchini (Site 0006) Bento Gonçalves, Rio Grande do Sul, Brazil

Fundação Universidade de Caxias do Sul (FUCS) - Instituto de Pesquisas em Saúde (IPS) (Site 0017) Caxias do Sul, Rio Grande do Sul, Brazil

ONCOSITE - Centro de Pesquisa Clinica em Oncologia (Site 0005) Ijuí, Rio Grande do Sul, Brazil

Hospital São Vicente de Paulo-Education and Research Management (Site 0007) Passo Fundo, Rio Grande do Sul, Brazil

View all 14 locations

View Trial Details